Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized open-label study of oral 5-ALA + sodium ferrous citrate in chemotherapy-induced anemia in patients with solid tumors
2013-002645-11Phase 2Unknown
- Sponsor
- SBI Pharmaceuticals
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of 5-aminolevulinic acid and sodium ferrous citrate in chemotherapy-induced anaemia (CIA) (2 arms), sponsored by SBI Pharmaceuticals. Primary endpoint: Safety and tolerability assessments. Status: unknown.
02
Drugs
5-aminolevulinic acidsodium ferrous citrate
03
Conditions
chemotherapy-induced anaemia (CIA)
Beyond the preview
Go deeper on 2013-002645-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002645-11.